…abilitation (PR) is an effective intervention for patients with chronic obstructive pulmonary disease (COPD) but impact typically only lasts 6–12 months. This paper …
COPD
This disease is selected. Its supporting articles are shown below.
Articles mentioning COPD
331 articles · page 9 of 28…glycopyrronium/formoterol (BGF) has been available in Spain for COPD treatment. Real-world evidence is essential to complement data …
…o-controlled trials, enrolled 1,874 patients (40–85 years) with COPD, moderate-to-severe airflow limitation, and type 2 inflammation…
…emographics are presented in table 1.Of 1,412,720 patients with asthma, 32.5% (459,651) had received a treatment review. Reviewed pati…
…tin C as an inflammatory marker in exacerbated and convalescent COPD patients. Inflammation. 2016 Apr;39(2):625–31.…
…ients with COPD and type 2 inflammation, regardless of comorbid CVD or metD.…
…adapted to meet PRSAS standards, on outcomes in patients from a COPD community service (CCS), compared to the former PR programme (P…
…Background Chronic Obstructive Pulmonary Disease (COPD) is associated with persistent airway inflammation, which…
… the NHS 10-year plan, refined into four fundamental pillars of COPD care: diagnosis, information, monitoring and treatment, which p…
…o smoking jointly are causally associated with a higher risk of chronic obstructive pulmonary disease (COPD) than each risk factor alone.Methods We used two large Da…
…ants completed core elements of frailty-focused care, including frailty assessment, personalised education and discharge planning. Pati…
…cystic fibrosis but has yet to be demonstrated in patients with chronic obstructive pulmonary disease (COPD).Research question To determine the feasibility and repea…